Table 2.

Recommendations for minoxidil based on International and National guidelines for managing androgenetic alopecia

Guideline/consensus	Recommendation
Expert consensus, India, 2019[9]	Minoxidil is the first-line therapy for AGA in men
Expert opinion, India, 2022[10]	Minoxidil is the mainstay treatment for AGA and FPHL
European Dermatology Forum, evidence-based guideline, 2017[11]	Topical minoxidil 2%–5% solution 1 mL or half a cap of 5% foam twice daily to improve or prevent AGA progression in male patients above 18 years with mild to moderate AGA
Asian Consensus Committee for AGA, guideline, 2012[12]	Mild-to-moderate AGA-monotherapy with 5% minoxidil in men and 2% or 3% minoxidil in women is recommended for 6–12 months
Japanese Dermatological Association’s guidelines for the management of AGA[13]	Topical 5% minoxidil twice daily for MPHL, and topical 1% minoxidil twice daily for FPHL, are recommended as the first-line treatments

AGA – Androgenetic alopecia; MPHL – Male pattern hair loss; FPHL – Female pattern hair loss